OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 126 filers reported holding OCULAR THERAPEUTIX INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $81 | -25.7% | 25,963 | +22.9% | 0.00% | – |
Q2 2023 | $109 | -92.6% | 21,123 | -92.4% | 0.00% | -100.0% |
Q1 2023 | $1,473 | +64.4% | 279,687 | -12.3% | 0.00% | – |
Q4 2022 | $896 | -93.6% | 318,834 | +9659.2% | 0.00% | – |
Q3 2022 | $14,000 | -78.8% | 3,267 | -80.0% | 0.00% | – |
Q2 2022 | $66,000 | -59.0% | 16,369 | -49.6% | 0.00% | – |
Q1 2022 | $161,000 | -90.8% | 32,481 | -87.0% | 0.00% | – |
Q4 2021 | $1,746,000 | +130.6% | 250,624 | +230.9% | 0.00% | – |
Q3 2021 | $757,000 | +227.7% | 75,737 | +362.7% | 0.00% | – |
Q2 2021 | $231,000 | -78.6% | 16,368 | -75.1% | 0.00% | -100.0% |
Q1 2021 | $1,077,000 | +132.1% | 65,631 | +192.6% | 0.00% | – |
Q4 2020 | $464,000 | +100.9% | 22,428 | -26.3% | 0.00% | – |
Q3 2020 | $231,000 | -6.1% | 30,447 | +3.0% | 0.00% | – |
Q2 2020 | $246,000 | +251.4% | 29,571 | +110.8% | 0.00% | – |
Q1 2020 | $70,000 | -58.3% | 14,029 | -67.0% | 0.00% | – |
Q4 2019 | $168,000 | -1.8% | 42,465 | -24.4% | 0.00% | – |
Q3 2019 | $171,000 | -41.0% | 56,197 | -14.5% | 0.00% | – |
Q2 2019 | $290,000 | +218.7% | 65,763 | +187.5% | 0.00% | – |
Q1 2019 | $91,000 | +3.4% | 22,878 | +2.9% | 0.00% | – |
Q4 2018 | $88,000 | -72.9% | 22,229 | -53.0% | 0.00% | – |
Q3 2018 | $325,000 | +100.6% | 47,346 | +96.5% | 0.00% | – |
Q2 2018 | $162,000 | -12.0% | 24,092 | -14.8% | 0.00% | – |
Q1 2018 | $184,000 | +922.2% | 28,262 | +587.0% | 0.00% | – |
Q4 2017 | $18,000 | -65.4% | 4,114 | -51.7% | 0.00% | – |
Q3 2017 | $52,000 | +642.9% | 8,520 | +955.8% | 0.00% | – |
Q2 2017 | $7,000 | -97.7% | 807 | -97.6% | 0.00% | – |
Q1 2017 | $308,000 | +1040.7% | 33,256 | +916.1% | 0.00% | – |
Q4 2016 | $27,000 | +1250.0% | 3,273 | +998.3% | 0.00% | – |
Q3 2016 | $2,000 | -90.0% | 298 | -92.4% | 0.00% | – |
Q2 2016 | $20,000 | +11.1% | 3,905 | +92.6% | 0.00% | – |
Q1 2016 | $18,000 | -61.7% | 2,028 | -61.3% | 0.00% | – |
Q4 2015 | $47,000 | -44.7% | 5,237 | -13.6% | 0.00% | – |
Q3 2015 | $85,000 | -14.1% | 6,059 | +28.1% | 0.00% | – |
Q2 2015 | $99,000 | +1314.3% | 4,729 | +2633.5% | 0.00% | – |
Q1 2015 | $7,000 | -88.5% | 173 | -93.4% | 0.00% | – |
Q4 2014 | $61,000 | – | 2,627 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 6,122,089 | $31,590 | 100.00% |
Opaleye Management Inc. | 5,780,000 | $29,824,800 | 7.13% |
DELTEC ASSET MANAGEMENT LLC | 1,974,797 | $10,189,953 | 2.23% |
Lynwood Capital Management Inc. | 262,500 | $1,354,500 | 1.72% |
Endurant Capital Management LP | 368,438 | $1,901,140 | 1.66% |
Knoll Capital Management, LLC | 200,000 | $1,032,000 | 1.25% |
Knoll Capital Management, LLC | 95,800 | $814,300 | 0.99% |
SECTORAL ASSET MANAGEMENT INC | 802,680 | $4,141,829 | 0.69% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 300,977 | $1,553,041 | 0.22% |
Cormorant Asset Management, LP | 645,000 | $3,328,200 | 0.19% |